Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

30,202 total articles

Wolfe Research Sees Large Upside to AMD Earnings Forecasts

Wolfe Research Sees Large Upside to AMD Earnings Forecasts

Wolfe Research told investors that a recent pre-quiet period conversation with AMD management was constructive and that there is material upside to consensus for calendar years 2026 and 2027. The firm highlighted stronger-than-expected server CPU demand, potential for additional gigawatt-scale MI450 customers, and wafer allocation flexibility as ke…

Tesla Held Between $405 and $419 as 4-Hour Chart Signals Indecision

Tesla Held Between $405 and $419 as 4-Hour Chart Signals Indecision

Tesla is trading inside a narrow 4-hour range, supported at $405 and capped near $419. Short-term indicators show a modest bullish tilt—MACD has crossed higher and RSI sits near 52.53—but declining volume and a dense resistance cluster around $417-$420 mean the market has not committed to a direction. Traders have defined entries, stops and targets…

FreeCast Shares Spike After DIRECTV Distribution Expansion

FreeCast Shares Spike After DIRECTV Distribution Expansion

FreeCast Inc. A stock rose sharply in morning trading after the company expanded its relationship with DIRECTV to distribute streaming services across its direct-to-consumer residential business and platform-as-a-service partner network. The June 11 announcement sparked heavy speculative buying, but recent quarterly filings show minimal revenue, su…

Ideaya Begins Combination Trial for MTAP-Deleted Tumors; Shares Rise

Ideaya Begins Combination Trial for MTAP-Deleted Tumors; Shares Rise

Ideaya Biosciences reported the initiation of a phase 1 clinical trial testing IDE892, an MTA-cooperative PRMT5 inhibitor, alongside IDE397, an MAT2A inhibitor, in patients with MTAP-deleted solid tumors. The combination trial has enrolled its first patient and targets non-small cell lung cancer and pancreatic cancer. The company noted supportive p…

Bandwidth announces $275M convertible note sale as shares plunge

Bandwidth announces $275M convertible note sale as shares plunge

Bandwidth Inc. said it will privately offer $275 million of convertible senior notes due 2032, triggering a 12.7% drop in its stock. The notes will be senior unsecured obligations, convertible into cash, Class A shares or a combination at the company’s election. Bandwidth will use portions of the proceeds for capped calls, share repurchases, repaym…

Fox shares plunge after $22 billion Roku takeover revealed; dilution and debt cited as main concerns

Fox shares plunge after $22 billion Roku takeover revealed; dilution and debt cited as main concerns

Fox's Class A shares tumbled 16.0% in morning trading after the company announced a definitive agreement to acquire Roku in a transaction valuing the connected-TV platform at roughly $22 billion in enterprise value. The pact pays $160 per Roku share through a mix of cash and Fox stock, requires issuance of about 152 million new Class A shares, and …

QQQ Climbs After U.S.-Iran Peace Accord, Nasdaq Tech Stocks Lead Rally

QQQ Climbs After U.S.-Iran Peace Accord, Nasdaq Tech Stocks Lead Rally

Invesco QQQ Trust jumped in early trading after a weekend announcement that the United States and Iran reached a peace agreement that reopened the Strait of Hormuz. The confirmation by President Trump late Sunday on social media triggered a broad futures rally, with technology and growth names that dominate the Nasdaq 100 powering gains. Falling oi…

Analyst: SpaceX IPO Could Propel Nvidia and Select Chipmakers as xAI, Terafab Spend Ramps

Analyst: SpaceX IPO Could Propel Nvidia and Select Chipmakers as xAI, Terafab Spend Ramps

Lynx Equity Strategies believes the recently completed SpaceX IPO - which aggregates an AI data center (xAI) and an advanced fabrication facility (Terafab) - will provide durable tailwinds for AI-focused chipmakers and semiconductor equipment suppliers. The firm highlights Nvidia as the standout beneficiary on the AI compute side and names Lam Rese…